WO2023136788 - PROCESS FOR THE PREPARATION OF A STERILE, HOMOGENEOUS SUSPENSION FOR INHALATION BY NEBULIZATION
National phase entry is expected:
Publication Number
WO/2023/136788
Publication Date
20.07.2023
International Application No.
PCT/TR2022/050032
International Filing Date
17.01.2022
Title **
[English]
PROCESS FOR THE PREPARATION OF A STERILE, HOMOGENEOUS SUSPENSION FOR INHALATION BY NEBULIZATION
[French]
PROCÉDÉ DE PRÉPARATION D'UNE SUSPENSION HOMOGÈNE STÉRILE POUR INHALATION PAR NÉBULISATION
Applicants **
ARVEN ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
CAN, Fatih
YILMAZ, Emine
CELIK SAKIZCI, Devrim
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2026 | |
| EPO | Filing, Examination, Granting | 9209 | |
| Japan | Filing, Examination, Granting | 2171 | |
| South Korea | Filing, Examination, Granting | 2023 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,169
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The invention relates to a simple, rapid, cost effective, timesaving and industrially convenient process for the preparation of a sterile, homogeneous suspension of niclosamide for inhalation by nebulization to treat SARS-CoV-2, the coronavirus that causes COVID-19. Further, the present invention also relates to a new inhalation composition comprising niclosamide, distilled water, dispersing or suspending agents, buffering agents, isotonic agents and preservatives.[French]
L'invention concerne un procédé simple, rapide, économique, qui permet de gagner du temps et convient à la production industrielle pour la préparation d'une suspension homogène et stérile de niclosamide pour inhalation par nébulisation afin de traiter le SARS-CoV-2, le coronavirus qui provoque la COVID-19. En outre, la présente invention concerne également une nouvelle composition à inhaler comprenant du niclosamide, de l'eau distillée, des agents dispersants ou suspensifs, des agents tampons, des agents isotoniques et des conservateurs.